ESR1 and cancer: However, the proliferation- and metastasis-promoting effect of E2 on cancer cells mediated by ERα seemed to overshadow the beneficial effect of ERβ agonists on endothelial cells when both cell types were exposed to E2 and subsequently treated with DPN.